Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697628
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2021-01-04
Brief Title:
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Sponsor:
Organization:
Seagen Inc